Expertise in
11
conditions

Dr. Smitha C. Reddy

Rheumatology
Office
15725 Pomerado Rd Ste 117, 
Poway, CA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
11
conditions
Office
15725 Pomerado Rd Ste 117, 
Poway, CA 

Overview

Smitha Reddy is a Rheumatologist practicing medicine in Poway, California.

Dr. Reddy is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Juvenile Dermatomyositis, Fibromyalgia, Rheumatoid Arthritis (RA), and Juvenile Primary Osteoporosis.

She is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 6 clinical trials. Dr. Reddy is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in CA

Hospital Affiliations

Palomar Medical Center Poway
Sharp Chula Vista Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Office
15725 Pomerado Rd Ste 117, Poway, CA 92064

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 20, 2025
Intervention Type: Drug
Study Drug: LY3361237
Study Phase: Phase 2
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 5 Less Clinical Trials

2 Total Publications

Transition of Methotrexate Polyglutamate Drug Monitoring Assay from Venipuncture to Capillary Blood-Based Collection Method in Rheumatic Diseases.
Transition of Methotrexate Polyglutamate Drug Monitoring Assay from Venipuncture to Capillary Blood-Based Collection Method in Rheumatic Diseases.
Journal: The journal of applied laboratory medicine
Published: July 27, 2018
Similar Doctors
Expertise in
13
conditions
Expertise in
13
conditions
Referral required
Before you request

UC San Diego

200 W Arbor Dr, 
San Diego, CA 
 (18.0 miles away)
800-926-8273
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kenneth Kalunian is a Rheumatologist practicing medicine in San Diego, California. Dr. Kalunian is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Cutaneous Lupus Erythematosus (CLE), Synovectomy, and Endoscopy. Dr. Kalunian is currently accepting new patients.

Expertise in
3
conditions
Expertise in
3
conditions
Referral may be required
Before you request

Jennifer Moreno Department Of Veterans Affairs Medical Center

3350 La Jolla Village Dr, 
San Diego, CA 
 (14.5 miles away)
858-552-8585
Languages Spoken:
English
Accepting New Patients

Robert Terkeltaub is a Rheumatologist practicing medicine in San Diego, California. Dr. Terkeltaub is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Gout, Arthritis, Calcium Pyrophosphate Arthritis, and Synovitis. Dr. Terkeltaub is currently accepting new patients.

Expertise in
4
conditions
Expertise in
4
conditions
Referral may be required
Before you request

UCSD Medical Offices South Pharmacy

4168 Front St, 
San Diego, CA 
 (18.0 miles away)
619-543-6248
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Gary Firestein is a Rheumatologist practicing medicine in San Diego, California. Dr. Firestein is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Vasculitis, Synovitis, and Tissue Biopsy. Dr. Firestein is currently accepting new patients.

Frequently Asked Questions about Dr. Smitha C. Reddy

How do I make an appointment with Dr. Smitha C. Reddy?

You can book an appointment with Dr. Smitha C. Reddy by calling their office at 858-442-1617. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Smitha C. Reddy a top-rated expert for Juvenile Dermatomyositis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Smitha C. Reddy is classified as an Distinguished expert for Juvenile Dermatomyositis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Smitha C. Reddy specialize in?

While Dr. Smitha C. Reddy is a Rheumatology, they have specific expertise in Juvenile Dermatomyositis, Fibromyalgia, and Rheumatoid Arthritis (RA). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Smitha C. Reddy participate in research or clinical trials?

Yes. Dr. Smitha C. Reddy has published 2 articles and abstracts on conditions like Juvenile Dermatomyositis. You can view a list of Dr. Smitha C. Reddy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Smitha C. Reddy accept my insurance?

Dr. Smitha C. Reddy accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 858-442-1617 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Reddy's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 32 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile